Skip to main content
IPSC logo

IPSC · Century Therapeutics, Inc.

Track IPSC — free
$2.07 +0.05 (+2.48%) At close · Aug 21
Market Cap
$372.11M
Shares
181.08M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-06-12 Russotti Gregory 2,584
2026-06-08 Russotti Gregory 524
2026-03-12 Russotti Gregory 10,076
2026-03-09 Russotti Gregory 479
2025-12-08 Pfeiffenberger Brent 476
2025-12-08 Russotti Gregory 526
2025-11-20 Cowan Chad 5,462
2025-11-17 Pfeiffenberger Brent 32,456
2025-09-08 Pfeiffenberger Brent 488
2025-09-08 Russotti Gregory 539
2025-08-18 Pfeiffenberger Brent 30,745
2025-06-09 Farid Adrienne 552
2025-06-09 Pfeiffenberger Brent 475
2025-06-09 Russotti Gregory 526
2025-05-16 Pfeiffenberger Brent 29,552
2025-05-05 Farid Adrienne 1,024
2025-03-10 Farid Adrienne 2,359
2025-03-10 Russotti Gregory 2,360
2025-03-10 Pfeiffenberger Brent 2,235
2025-02-18 Pfeiffenberger Brent 34,712
2025-02-03 Farid Adrienne 1,054
2024-11-04 Farid Adrienne 1,033
2024-08-05 Farid Adrienne 1,073
2024-07-26 Russotti Gregory 586
2024-07-24 Russotti Gregory 1,600
2024-07-23 Russotti Gregory 200
2024-06-20 Russotti Gregory 5,000
2024-06-05 Russotti Gregory 5,000
2024-05-20 Russotti Gregory 5,000
2024-05-06 Russotti Gregory 5,000
2024-05-03 Farid Adrienne 913
2024-04-22 Russotti Gregory 5,000
2024-03-20 Diem Michael Craig 8,033
2024-03-18 Diem Michael Craig 2,725
2024-03-15 Diem Michael Craig 9,242
2024-03-07 Farid Adrienne 22,831
2024-03-07 Diem Michael Craig 986
2024-03-06 Diem Michael Craig 9,014
2024-03-06 Farid Adrienne 30,684
2024-02-16 Farid Adrienne 485
2024-02-06 Diem Michael Craig 2,011
2024-02-06 Farid Adrienne 1,784
2024-02-05 Diem Michael Craig 2,321
2024-02-05 Farid Adrienne 2,035
2023-03-23 Borges Luis 15,597
2023-03-22 Borges Luis 65,698
2023-03-21 Borges Luis 63,616
Showing 1–47 of 47 filings
Key facts CIK 1850119 CUSIP 15673T100 13F (30d) 96 filings 95 filers Visit website Investor relations